Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomized trial showed.

Trial findings shows that urodynamics investigations do not lead to symptom improvement in women with refractory overactive bladder or urgency predominant urinary incontinence. The addition of ...

IRVINE, Calif.--(BUSINESS WIRE)--Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced ...

Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...